HOME >> MEDICINE >> NEWS
Europe's first polar-orbiting weather satellite ready for launch

Following the roll out to the launch pad and erection at the launch tower at the weekend, MetOp is ready for launch at 18:28 CEST tomorrow from the Baikonur Cosmodrome in Kazakhstan. The launch of Europe's first polar-orbiting weather satellite is set to make a major contribution to global weather forecasting and climate monitoring.

The roll out to the launch pad and erection of the Soyuz rocket at the launch tower took place on Saturday 14 October. Carried by train, the launcher left the hall where the upper-composite, which comprises the MetOp satellite and the Fregat upper-stage, had been integrated with the third-stage of the launch vehicle. The train slowly pulled its cargo over to the launch pad where the rocket was erected with the help of a huge hydraulic ram. The final countdown rehearsal followed, confirming that the launch will go-ahead tomorrow.

Once launched, MetOp will be renamed 'MetOp-A' as it is the first in a series of three satellites developed as part of a joint undertaking between ESA and the European Organisation for the Exploitation of Meteorological Satellites (EUMETSAT), whereby MetOp forms the space segment of EUMETSAT's Polar System (EPS). In addition, MetOp is the European contribution to a new cooperative venture with the American National Oceanic and Atmospheric Administration (NOAA), so that MetOp and NOAA satellites fly in complementary orbits to maximise the coverage area over which observations are made.

MetOp is Europe's first polar-orbiting satellite dedicated to operational meteorology and with its array of sophisticated instruments, this weather satellite promises to provide data of unprecedented accuracy and resolution on a whole host of different variables such as atmospheric temperature and humidity, wind speed and direction over the ocean, ozone and other trace gases, thus making a major contribution to global weather forecasting and climate monitoring capabilities. The payload also includes a
'"/>

Contact: Simonetta Cheli
simonetta.cheli@esa.int
39-694-180-350
European Space Agency
16-Oct-2006


Page: 1 2

Related medicine news :

1. New launch date for Europes first polar-orbiting weather satellite
2. Survey finds care for Europes adults with congenital heart disease is inadequate
3. Study highlights gaps in Europes preparedness plans for pandemic influenza
4. Envisat sees smoke from Europes worst peacetime fire
5. RAND presents first Victor Fuchs Research Award to economists at Carnegie Mellon University
6. Worcester Polytechnic Institute to host national forum on locating first responders inside buildings
7. Screening for behavioral health first step to getting treatment
8. Polish journalist scoops first prize in prestigious European award
9. Poker match pits an vs. machine in world first match
10. Dasatinib shows high early response rate as first treatment for chronic myelogenous leukemia
11. World first medical treatment announced by researchers

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Europe first polar orbiting weather satellite ready for launch

(Date:11/26/2014)... The report “Laboratory Information System/LIS Market by ... End User Labs (Clinical, Molecular Diagnostic, Blood Bank, ... Global Forecast to 2019” provides a detailed overview ... market trends, and strategies impacting the LIS market ... revenue and market growth. , Browse 85 market ...
(Date:11/26/2014)... (PRWEB) November 26, 2014 The ... Cardiology have launched a partnership designed to improve ... for congestive heart failure (CHF) patients in the ... staff and Lourdes Cardiology team will help CHF ... supervised protocols. This partnership pairs the Cardiac Recovery ...
(Date:11/26/2014)... November 26, 2014 The American ... the Association’s new director of meetings and conferences. ... annual meeting, special events and conferences. , ... this post,” said AAA Executive Director Ed Liebow. ... enthusiasm and energy. She was recognized in January ...
(Date:11/26/2014)... (PRWEB) November 26, 2014 The city ... water shortages, is moving forward with a plan to ... water.* Radio host Sharon Kleyne supports the San Diego ... Water Management” (TWM). According to Kleyne, by recycling water ... import new water could be greatly reduced. (Spagat, E, ...
(Date:11/26/2014)... (PRWEB) November 26, 2014 With a ... surgeon Dr. Steven Meier has enhanced the user ... current and prospective patients an online destination for orthopedic ... excited to present the new and improved version of ... make it easier than ever for current and prospective ...
Breaking Medicine News(10 mins):Health News:Laboratory Information Systems Market by Type, Delivery Mode & End Users is Estimated to Reach $1,806.1 Million by 2019 - New Research Report by MarketsandMarkets 2Health News:Laboratory Information Systems Market by Type, Delivery Mode & End Users is Estimated to Reach $1,806.1 Million by 2019 - New Research Report by MarketsandMarkets 3Health News:Laboratory Information Systems Market by Type, Delivery Mode & End Users is Estimated to Reach $1,806.1 Million by 2019 - New Research Report by MarketsandMarkets 4Health News:Advanced Heart Failure Recovery Program comes to Deptford Center for Rehabilitation and Healthcare 2Health News:Advanced Heart Failure Recovery Program comes to Deptford Center for Rehabilitation and Healthcare 3Health News:American Anthropological Association Appoints New Director of Meetings and Conferences: Ushma Suvarnakar 2Health News:Global fresh water advocate supports San Diego wastewater recycling plan 2Health News:Global fresh water advocate supports San Diego wastewater recycling plan 3Health News:Los Angeles Orthopedic Surgeon Dr. Steven Meier Announces Relaunch Of Practice Website 2
(Date:11/26/2014)... LONDON , Nov. 25, 2014 Amgen (NASDAQ: ... ) today announced that AMAGINE-2 TM , a pivotal, multi-arm ... than 1,800 patients with moderate-to-severe plaque psoriasis, met its primary ... placebo at week 12. Brodalumab 210 mg given every two ... to be superior to Stelara on the primary endpoint of ...
(Date:11/26/2014)... DIEGO , Nov. 25, 2014 Halozyme Therapeutics, ... the Piper Jaffray Healthcare Conference in New York ... EDT/10:00 a.m. PDT . Dr. Helen Torley , ... The presentation will be webcast through the "Investors" ... a recording will be made available for 90 days following ...
(Date:11/24/2014)... -- CryoLife, Inc. (NYSE: CRY ), a leading medical ... surgery, announced today that it will participate in the upcoming ... December 3, 2014 at The New York Palace Hotel in ... live webcast of the Company,s presentation is scheduled to begin ... the company by Pat Mackin , President and Chief ...
Breaking Medicine Technology:Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 2Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 3Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 4Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 5Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 6Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 7Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 8Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 9Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 10Halozyme Therapeutics To Present At The Piper Jaffray Healthcare Conference 2CryoLife to Present at 26th Annual Piper Jaffray Healthcare Conference 2CryoLife to Present at 26th Annual Piper Jaffray Healthcare Conference 3
Cached News: